- Home
- VABK vs LYEL Comparison
VABK vs LYEL Comparison
Compare VABK & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VABK
- LYEL
- Stock Information
- Founded
- VABK 1998
- LYEL 2018
- Country
- VABK United States
- LYEL United States
- Employees
- VABK N/A
- LYEL N/A
- Industry
- VABK Major Banks
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- VABK Finance
- LYEL Health Care
- Exchange
- VABK Nasdaq
- LYEL Nasdaq
- Market Cap
- VABK 197.3M
- LYEL 207.7M
- IPO Year
- VABK N/A
- LYEL 2021
- Fundamental
- Price
- VABK $36.90
- LYEL $8.22
- Analyst Decision
- VABK
- LYEL Sell
- Analyst Count
- VABK 0
- LYEL 2
- Target Price
- VABK N/A
- LYEL $1.00
- AVG Volume (30 Days)
- VABK 4.0K
- LYEL 619.3K
- Earning Date
- VABK 07-18-2025
- LYEL 05-13-2025
- Dividend Yield
- VABK 3.88%
- LYEL N/A
- EPS Growth
- VABK 3.77
- LYEL N/A
- EPS
- VABK 3.30
- LYEL N/A
- Revenue
- VABK $54,953,000.00
- LYEL $65,000.00
- Revenue This Year
- VABK N/A
- LYEL N/A
- Revenue Next Year
- VABK N/A
- LYEL N/A
- P/E Ratio
- VABK $11.32
- LYEL N/A
- Revenue Growth
- VABK 1.60
- LYEL N/A
- 52 Week Low
- VABK $28.71
- LYEL $0.39
- 52 Week High
- VABK $44.00
- LYEL $10.30
- Technical
- Relative Strength Index (RSI)
- VABK 48.91
- LYEL 98.86
- Support Level
- VABK $36.83
- LYEL $0.39
- Resistance Level
- VABK $38.85
- LYEL $0.43
- Average True Range (ATR)
- VABK 0.84
- LYEL 0.22
- MACD
- VABK -0.13
- LYEL 0.50
- Stochastic Oscillator
- VABK 12.90
- LYEL 79.01
About VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.